下一个

自动播放

Clinical Trial for Advanced Bile Duct Cancer

0 意见 • 07/01/23
分享
嵌入
administrator
administrator
订户
0

Learn about a phase II multi-center study evaluating combination immunotherapy for advanced cholangiocarcinoma (bile duct cancer) with pembrolizumab and Sylatron (peginterferon alfa-2b): HCRN GI16-263. https://hoosiercancer.org/clin....ical-trials/trial/gi

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放